Member Profile
Name: William Joseph Lambert
Country: USA
City: Incline Village
State/Province: NV
ACS Member: Member
Local Section: L629,Sierra Nevada
International Chapter:
Technical Division Membership:
Technical Division Membership Emeritus:
Subdivision Member:
ACS Activities:
Company/Institution Name: Module 3 Pharmaceutical Consulting
Career Stage: Retired
Research and Special Interests: • Bill’s 30+ years of experience includes: • Executive team membership reporting to CEO for two public companies including one that was venture capital funded and had a successful product launch and IPO • Writing and review of Module 3 CMC section of eCTD regulatory filings (IND, IMPD, NDA) • Experience working with corporate board of directors • Significant experience in due diligence and consulting business development groups from both the acquirer and acquiree standpoint • Member of multiple development leadership teams for both big pharmaceutical and big biotech companies • Optimization and lead selection of drug candidates, both large and small molecule • Experience managing CMOs, CDOs, and CROs • Contributed to the development and global regulatory registration efforts of several marketed drugs including Corvert (anti-arrhythmic), Trovan (antibiotic), Halaven (anti-cancer), Exparel (post-surgical pain), Fasenra (benralizumab, asthma), and Omidria (ophthalmic surgery) • Experience in discovery support, development, sourcing, and commercial operations. • Managed budgets of up to $20MM • Knowledgeable in intellectual property including the management of a large patent portfolio • Member of multiple scientific advisory boards • Subject matter expert in sterile product formulation and analytical development, aseptic processing, tech transfer, drug delivery, combination product devices, cGMPs, and life cycle management
Area of Expertise: pharmaceutical development, formulation, analytical, CMC, sterile products
Years of Expertise: 21-25
LinkedIn Profile:
ORCID Account:
Contact Me
Online Status
Offline
Date Last Visited
‎12-15-2020 04:25 AM